Terms: = Gastric cancer AND DDB2, Q92466, 1643, ENSG00000134574, FLJ34321 AND Treatment
5 results:
1. Establishment of Golgi apparatus-related genes signature to predict the prognosis and immunotherapy response in gastric cancer patients.
Liu R; Chu W; Liu X; Hong J; Wang H
Medicine (Baltimore); 2024 Mar; 103(11):e37439. PubMed ID: 38489711
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of endoscopic full-thickness resection and ligation-assisted endoscopic full-thickness resection for small (≤ 1.5 cm) gastric subepithelial tumors originating from muscularis propria.
Gu L; Wu Y; Yi J; Ouyang M; Liu X
Surg Endosc; 2023 May; 37(5):3796-3806. PubMed ID: 36690893
[TBL] [Abstract] [Full Text] [Related]
3. Enteral Stents for Malignant gastric Outlet Obstruction: Low Reintervention Rates for Obstruction due to Pancreatic Adenocarcinoma Versus Other Etiologies.
Orr J; Lockwood R; Gamboa A; Slaughter JC; Obstein KL; Yachimski P
J Gastrointest Surg; 2021 Mar; 25(3):720-727. PubMed ID: 32077045
[TBL] [Abstract] [Full Text] [Related]
4. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
[TBL] [Abstract] [Full Text] [Related]
5. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
[TBL] [Abstract] [Full Text] [Related]
